Clinical Efficacy of Talisadi Churna in the Management of Kasa (Stable Chronic Bronchitis)

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Patients of chronic stable bronchitis suffering from minimum of two years.(Chronic bronchitis is defined clinically as chronic Productive cough for 3 months in each of 2 successive years in that patient in whom other causes of productive cough have been excluded)
•2 Stable symptoms for the past 2 weeks i.e. unchanged amount & colour of daily sputum
•3 FEV1 > 80%
•4 Patient willing and able to participate in the study for 16 weeks

•1.Any other pulmonary diagnosis like Emphysema, Cor pulmonale, Cyanosis, Pneumonia, Asthma, Cystic fibrosis, Tuberculosis, Lung cancer etc.
•2.Patients of Diabetes Mellitus
•3.Patients with poorly controlled Hypertension (equal or more than 160 / 100 mmHg).
•4.Patients on prolonged ( > 6 weeks) medication with corticosteroids, bronchodilators, Mast cell stabilizers, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
•5.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders etc).
•6.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•7.Symptomatic patients with clinical evidence of Heart failure.
•8.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL).
•9.Smokers/alcoholics and/or drug abusers.
•10.Patients who have completed participation in any other clinical trial during the past six (06) months.
•11.Any other condition which the Investigator thinks may jeopardize the study.

发起方